Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

KFC Hall

Jan 28, 2016 9:00 AM - Jan 29, 2016 6:00 PM

1-6-1 Yokoami, Sumida-ku, Tokyo, 130-0015 Japan

19th Annual Workshop in Japan for Clinical Data Management

The registrants will have access to presentation PDFs through Friday, July 29, 2016.

Session 1 - How Should We Collect and Leverage the Medical Data in the "Real World"?

Session Chair(s)

Mika  Ogasawara

Mika Ogasawara

Data Quality Lead, Biometrics and Data Management

Pfizer R&D Japan G.K., Japan

Motohide  Nishi, MBA

Motohide Nishi, MBA

Japan Site Leader & VP Professional Services

Medidata Solutions K.K., Japan

How should we collect and leverage the medical data in the “real world” after drugs/ medical devices are launched in order to make the information more beneficial to patients, healthcare workers, government, academia and industry? In this session we will have various discussions about the real world data (RWD) post new drug/medical device approval, e.g. current situation and future possibilities. A drug lag issue is being eliminated and now drug discovery form Japan and “Iku-yaku” have become a hot topic in Japan. So, we believe it is time to rethink about what and how to collect and utilize the post-marketing study/surveillance data and RWD, and furthermore consider the other methodologies to leverage the RWD for providing the better means of cure. This session is expected to inspire the audience to learn and think about data management in non-interventional studies and data science for RWD.

Speaker(s)

Nathan R. Crisel

Central Real World Informatics Function: Operational and Organizational Considerations

Nathan R. Crisel

Astellas US LLC, United States

Director, Real World Informatics and Analytics Function

Kotonari  Aoki, MS

Use of Real World Data

Kotonari Aoki, MS

Chugai Pharmaceutical Co., Ltd., Japan

Head of Real World Data Science Dept. Drug Safety Div.

Yasuhiro  Fujiwara, MD, PhD

Yasuhiro Fujiwara, MD, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Chief Executive

Osamu  Komiyama

Osamu Komiyama

Pfizer R&D Japan G.K., Japan

Senior Manager, Statistical Research & Data Science

Hironobu  Saito, PhD

Hironobu Saito, PhD

Tottori University, Chromosome Egineering Research Center, Japan

Specially Appointed Professor

Mayumi  Shikano, PhD

Mayumi Shikano, PhD

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Associate Center Director (for Advanced Review with Electronic Data Promotion)

Steve  Wilson, PhD

Steve Wilson, PhD

FDA, United States

Senior Staff Fellow, OB, OTS, CDER

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.